4
Changes in Ownership
DEXCOM INC Filed Acc 0001093557-25-000062
EVP, Chief Financal Officer sold 7,000 shares at an average $73.83 ($516,830)
- EVP, Chief Financal Officer acquired 58,704 shares (grant or award)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Sylvain Jereme M · EVP, Chief Financal Officer
Table I: Non-derivative
5 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-03-08 | Grant or award : show line 1 in the form 10b5-1 | +35,906 | 119,684 | D | ||
| 2025-03-08 | Grant or award : show line 2 in the form 10b5-1 | +22,798 | 142,482 | D | ||
| 2025-03-10 | Sale : show line 3 in the form 10b5-1 | −2,670 | $73.22 | $195,489 | 139,812 | D |
| 2025-03-10 | Sale : show line 4 in the form 10b5-1 | −3,203 | $74.04 | $237,151 | 136,609 | D |
| 2025-03-10 | Sale : show line 5 in the form 10b5-1 | −1,127 | $74.70 | $84,189 | 135,482 | D |
| Open-market sales · 7,000 sh · avg $73.83 · $516,830 | ||||||
Loading xslF345X05/wk-form4_1741735014.xml…